During the past decade, Klinikum Nürnberg Sud conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 8 clinical trials were completed, i.e. on average, 88.9% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Klinikum Nürnberg Sud" #1 sponsor was "Biostable Science & Engineering" with 2 trials, followed by "Deutsches Herzzentrum Muenchen" with 2 trials sponsored, "Dr. Sabrina Overhagen" with 2 trials sponsored, "ResMed" with 2 trials sponsored and "Abbott Medical Devices" with 2 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Nürnberg Sud" #1 collaborator was "Boston Scientific Corporation" with 2 trials as a collaborator, "AXIOM Real Time Metrics" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Balt Extrusion" with 1 trials as a collaborator and "Bentley InnoMed GmbH" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Klinikum Nürnberg Sud" are "Acute Coronary Syndrome" (2 trials), "Aortic Insufficiency" (2 trials), "Atrial Fibrillation" (2 trials), "Coronary Artery Disease" (2 trials) and "Thoracoabdominal Aortic Aneurysm, Without Mention of Rupture" (2 trials). Many other conditions were trialed in "Klinikum Nürnberg Sud" in a lesser frequency.

Most popular intervention types in "Klinikum Nürnberg Sud" are "Device" (15 trials), "Procedure" (4 trials), "Other" (3 trials), "Biological" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "ACURATE TA™ Transapical Aortic Bioprosthesis" (1 trials), "Aspirin" (1 trials), "BGP+ Stent Graft System as bridging stent" (1 trials), "BeGraft Peripheral (BGP) Stent Graft System as bridging stent" (1 trials) and "Botulinum toxin type A" (1 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Nürnberg Sud" are 26 trials for "All" genders.

Currently, there are NaN active trials in "Klinikum Nürnberg Sud". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Klinikum Nürnberg Sud, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Nürnberg Sud, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 13 trials that are defined as “Not Applicable".